Circular RNA profiling reveals abundant and diverse circRNAs of SARS-CoV-2, SARS-CoV and MERS-CoV origin
preprint
OA: closed
Abstract
ABSTRACT Circular RNAs (circRNAs) encoded by DNA genomes have been identified across host and pathogen species as parts of the transcriptome. Accumulating evidences indicate that circRNAs play critical roles in autoimmune diseases and viral pathogenesis. Here we report that RNA viruses of the Betacoronavirus genus of Coronaviridae , SARS-CoV-2, SARS-CoV and MERS-CoV, encode a novel type of circRNAs. Through de novo circRNA analyses of publicly available coronavirus-infection related deep RNA-Sequencing data, we identified 351, 224 and 2,764 circRNAs derived from SARS-CoV-2, SARS-CoV and MERS-CoV, respectively, and characterized two major back-splice events shared by these viruses. Coronavirus-derived circRNAs are more abundant and longer compared to host genome-derived circRNAs. Using a systematic strategy to amplify and identify back-splice junction sequences, we experimentally identified over 100 viral circRNAs from SARS-CoV-2 infected Vero E6 cells. This collection of circRNAs provided the first line of evidence for the abundance and diversity of coronavirus-derived circRNAs and suggested possible mechanisms driving circRNA biogenesis from RNA genomes. Our findings highlight circRNAs as an important component of the coronavirus transcriptome. Summary We report for the first time that abundant and diverse circRNAs are generated by SARS-CoV-2, SARS-CoV and MERS-CoV and represent a novel type of circRNAs that differ from circRNAs encoded by DNA genomes.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (33)
- doi:10.1038/s41586-020-2012-7 via crossref
- doi:10.1038/s41564-020-0695-z via crossref
- doi:10.1146/annurev-virology-100114-055218 via crossref
- doi:10.1016/j.cell.2020.04.011 via crossref
- doi:10.1016/j.pharmthera.2018.01.010 via crossref
- doi:10.1261/rna.035667.112 via crossref
- doi:10.1016/j.molcel.2018.06.034 via crossref
- doi:10.15252/embr.201643581 via crossref
- doi:10.1016/j.cell.2018.12.021 via crossref
- doi:10.1016/j.bbrc.2018.09.158 via crossref
- doi:10.1038/s41419-019-1744-5 via crossref
- doi:10.1016/j.virol.2019.01.014 via crossref
- doi:10.1371/journal.ppat.1007206 via crossref
- doi:10.1073/pnas.1811728115 via crossref
- doi:10.1073/pnas.1816183115 via crossref
- doi:10.1128/mbio.03027-19 via crossref
- doi:10.1038/s41467-019-10246-5 via crossref
- doi:10.1261/rna.043687.113 via crossref
- doi:10.1016/s2666-5247(20)30004-5 via crossref
- doi:10.1038/s41586-020-2577-1 via crossref
- doi:10.1080/22221751.2020.1738277 via crossref
- doi:10.1093/bib/bbx014 via crossref
- doi:10.1186/s13073-019-0614-1 via crossref
- doi:10.1093/bioinformatics/btp324 via crossref
- doi:10.1038/323558a0 via crossref
- doi:10.1002/iid3.366 via crossref
- doi:10.1038/nmeth.1923 via crossref
- doi:10.1093/bioinformatics/btv566 via crossref
- doi:10.1038/nature11928 via crossref
- doi:10.1016/0092-8674(88)90141-9 via crossref
- doi:10.1038/s41392-020-00372-8 via crossref
- doi:10.1016/j.virol.2020.05.015 via crossref
- doi:10.21769/bioprotoc.2775 via crossref
Source provenance
- crossref
- last seen: 2026-05-28T01:00:17.939164+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-28T06:55:22.213180+00:00